Prognostic Value of FDG Uptake in Stage I Non-Small-Cell Lung Cancer

被引:0
|
作者
Kwon, Woocheol [1 ]
Howard, Brandon A. [2 ]
Herndon, James E. [2 ]
Patz, Edward F., Jr. [2 ]
机构
[1] Yonsei Univ, Wonju Coll Med, Wonju Severance Christian Hosp, Dept Radiol, Wonju, South Korea
[2] Duke Univ, Med Ctr, Durham, NC 27710 USA
关键词
D O I
10.1097/JTO.0000000000000637
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E102 / E102
页数:1
相关论文
共 50 条
  • [1] Prognostic value of FDG uptake in early stage non-small cell lung cancer
    Hanin, Francois-Xavier
    Lonneux, Max
    Cornet, Julien
    Noirhomme, Philippe
    Coulon, Corinne
    Distexhe, Julien
    Poncelet, Alain J.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (05) : 819 - 823
  • [2] Re: Prognostic value of FDG uptake in early stage non-small cell lung cancer
    Chong, Chee Fui
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 34 (04) : 932 - 932
  • [3] Prognostic Value of Computed Tomography Morphologic Characteristics in Stage I Non-Small-Cell Lung Cancer
    Meniga, Inja Neralic
    Tiljak, Mirjana Kujundzic
    Ivankovic, Davor
    Aleric, Ivan
    Zekan, Mirta
    Hrabac, Pero
    Mazuranic, Ivica
    Puljic, Igor
    CLINICAL LUNG CANCER, 2010, 11 (02) : 98 - 104
  • [4] Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer
    Tong, An-Na
    Han, Shao-Rong
    Yan, Peng
    Gong, Hai
    Zhao, Hui
    Yao, Hui
    Wang, Yan-Ming
    MEDICAL ONCOLOGY, 2014, 31 (01)
  • [5] Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer
    An-Na Tong
    Shao-Rong Han
    Peng Yan
    Hai Gong
    Hui Zhao
    Hui Yao
    Yan-Ming Wang
    Medical Oncology, 2014, 31
  • [6] A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer
    Sandoval, Juan
    Mendez-Gonzalez, Jesus
    Nadal, Ernest
    Chen, Guoan
    Carmona, F. Javier
    Sayols, Sergi
    Moran, Sebastian
    Heyn, Holger
    Vizoso, Miguel
    Gomez, Antonio
    Sanchez-Cespedes, Montse
    Assenov, Yassen
    Mueller, Fabian
    Bock, Christoph
    Taron, Miquel
    Mora, Josefina
    Muscarella, Lucia A.
    Liloglou, Triantafillos
    Davies, Michael
    Pollan, Marina
    Pajares, Maria J.
    Torre, Wenceslao
    Montuenga, Luis M.
    Brambilla, Elisabeth
    Field, John K.
    Roz, Luca
    Lo Iacono, Marco
    Scagliotti, Giorgio V.
    Rosell, Rafael
    Beer, David G.
    Esteller, Manel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4140 - +
  • [7] Prognostic factors in stage III non-small-cell lung cancer
    Ademuyiwa, Foluso O.
    Johnson, Cynthia S.
    White, Angela S.
    Breen, Timothy E.
    Harvey, Jayme
    Neubauer, Marcus
    Hanna, Nasser H.
    CLINICAL LUNG CANCER, 2007, 8 (08) : 478 - 482
  • [8] Prognostic factors of advanced stage non-small-cell lung cancer
    Kwas, H.
    Guermazi, E.
    Khattab, A.
    Hrizi, C.
    Zendah, I.
    Ghedira, H.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2017, 73 (04) : 180 - 187
  • [9] Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer
    Firat, S
    Bousamra, M
    Gore, E
    Byhardt, RW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (04): : 1047 - 1057
  • [10] Prognostic value of genomic damage in non-small-cell lung cancer
    C de Juan
    P Iniesta
    FJ Vega
    MA Peinado
    C Fernandez
    T Caldés
    M Jose Massa
    JA López
    A Sánchez
    AJ Torres
    JL Balibrea
    M Benito
    British Journal of Cancer, 1998, 77 : 1971 - 1977